Strategy
Johnson & Johnson Raises Its Outlook, but MedTech Misses Expectations Again
Pharmaceutical growth supported a modest guidance increase, while medical-device sales of $8.64 billion fell short of Wall Street expectations for a second consecutive quarter.
AF
By Anna Ferreira
Oct 18, 2026 · 5 min read
Johnson & Johnson raised its full-year sales and earnings outlook after third-quarter revenue topped expectations, but a second consecutive shortfall in its medical-device business exposed a widening performance gap inside the health-care company.
Discussion (0)
Sign in to join the discussion.
Loading comments…
AF
Anna Ferreira
Senior Correspondent, Corporate Strategy
Anna Ferreira writes for Corporate Insider Inc.